Recently, purine degradation products, especially hypoxanthine, have been studied in relation to perinatal asphyxia. However the final degradation product, uric acid (UA) received l~ttle attention. We previously showed a correlation between cord UA levels and Apgar scores in a low risk populat~on.
were measured in blood samples taken from 2 7 5 newborns admitted t o the NlCU in Leuven. In 67 patients, UA and CREA were also measured in a urine sample on the first day of life. A negative correlation w a s found between the 1 min Apgar score and both the maxlmal serum UA concentratlon In the f~r s t 24h ( r = -0.23, p < 0 . 0 2 5 ) and the corrected excretion of UA = (urine,, x serum,,l/urine,, ( r = -0.45, p < 0 . 0 0 5 ) . All newborns were classified a s normal, moderate or severe w~t h respect t o per~natal asphyxia. Newborns with severe asphyx~a (n = 141 needed to have obvious neurological and cerebcal ultrasound abnortralities a t discharge. No significant differences were found in serum UA levels between the groups on the day of birth and the day thereafter due t o the large variation in the normal group ( 3 0 3 + 7 1 and 3 5 1 * 1 7 2 pmolll).
However, on each of the days 2 to 10. serum UA levels were significantly ( p < 0 . 0 5 ) higher in the severe asphyxia group compared to the other groups. Moreover, all 1 3 newborns w~t h severe asphyx~a w h o had serum UA measured on day 2 or later had values higher than the normal range (defined a s m e a n + 2 S D of the normal group. 357, 2 9 7 and 1 7 2 pmolll on days 2.3 and 41. W e conclude that newborns with severe perinatal asphyxia have increased levels of serum UA between days 2 and 1 0 of life. There is evidence for a critical role of the tnreraction between endogenous EndotheliumDerived Relaxing Factor or Nitric Oxd~de (NO) and Ang~otensin I1 (Ang IT) in the control of adult rend hemodynamicr. This study was designed to explore if such NO-Ang I 1 interaction exists In the isolated developing rabb~r kidney, perfured in presence of indomethacln 10 pnol/L and to see how such interaction evolves with renal maturation. Results: In rabbit.' with a postnatal age of 7 and 20 days, it was shown that under control conditions, vasoconstrictory responses to low concentrations of Ang IJ (10" mol/L) decrease with kldneyl age from 15,8% to 8,9%, whereas responses to high concentrations of Ang II (10' mol/L); increase with kidney development from 32,3% ro 55,6%. Competitive inhibition of NO synthase by nitro-L-arginine methyl ester (L-NAME) (103 pmol/L) augmented. vasoconstrictory responses to 10.'' mol/L Ang I1 by about 80% in k~dneys of both 7 and 29 days. In both cases, L-arginine (substrate of NO rynthase), was able to reverse the effect of Li NAME. At both ages, the effect of L-NAME on 1 0 h o l / L Ang I1 was markedly morel discrete. In conclusion, 1) the developing kidney doer exhibit an Ang 11-NO interactionr and vasoconstrictory responses to low conc. of Ang 11 decreased with age, development attribution of different AT receptor subtypes may perhaps be involved ~n borh phenomena).
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MEASURPIENT OF BRONCHIAL OBSTRUCTION BY RESPIRATORY I i i E Z 5 l u u C~~ PLETHYSMCGRAPHY ( R I P ) I N SCHOOL CHILDREN Peter Banovcin, Yvone Gllsewell, Horst von der Hardt Dept. Pediatrics, Jesenius Med. Fac., Martin, Slovakia and Dept. P e d i a t r i c s , Med. S c h w l Hannover, Hannover. Germany
Previously reported s t u d i e s documented t h a t t h e r a t i o of time t a k e n . t o reach peak expiratory flow t o t o t a l expiratory time
(?me/TE) measured by pneumotachograph (PPG) agreed with those measured by R I P (11. We used RIP t o measure Tnie/TE before and a f t e r bronchial challenge with cold a i r (CACHI i n a group of 22 school-aged children with h i s t o r y of asthma. Noncalibrated r i b cage (TI, abdominal (A) and s m e d T+A (S) s i a n a l s were d i f f e r e n t i a t e d t o flow from which TPme/TE. Anne/ TE an: SRnelTE were calculated. 
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A NEW HPLC TECHNIQUE FOR THE ANALYSIS OF SURFACTANT PHOSPHOLIPID COHPOSITION AND SATWRATION Wolfgang B e r n h a r d , Ileana M a r t i n -C a r l e r a , Anne A m i n g , H o r s t v o n der H a r d t ; D e p a r t m e n t of Pediatric P n e u m o n o l o g y , M e d i c a l S c h w l E a n n o v e r , FRG
An i s o c r a t i c HPLC s y s t e m f o r t h e s e p a r a t i o n o f a l l m a j o r p h o s p h o l i p i d s p e c i e s w a s d e v e l o p e d u s i n g u l t r a v i o l e t ( W ) a b s o r p t i o n ( 2 0 5 nm) a n d s u b s e q u e n t f l u o r e s c e n c e (FL) d e t e c t i o n w i t h 1,6-diphenyl-1,3,5-hexatriene. F o r FL t h e s e n s i t i v i t y w a s a l m o s t i d e n t i c a l f o r a l l p h o s p h o l i p i d s e xc e p t p h o s p h a t i d y l i n o s i t o l a n d lysophosphatidylcholine, b u t f o r W a b s o r p t i o n t h e r e w e r e g r e a t d i f f e r e n c e s d e p e n d i n g o n t h e s a t u r a t i o n of p h o s p h o l i p i d f a t t y a c i d s . D i p a l m i t oy l p h o s p h a t i d y l c h o l i n e s h o w e d n e a r l y n o W b u t g o o d FL resp o n s e . W t o FL r a t i o w a s c h a r a c t e r i s t i c f o r p h o s p h a t i d y lc h o l i n e s w i t h d i f f e r e n t f a t t y a c i d s a t u r a t i o n . Q u a n t i t a t io n o f p h o s p h o l i p i d s w i t h HPLC u s i n g M o n o m e t h y l p h o s p h a t i -
dylethanolamine(dioleoyl) a s a n i n t e r n a l s t a n d a r d g a v e t h e s a m e r e s u l t s a s p h o s p h o l i p i d p h o s p h o r u s q u a n t i f i c a t i o n a ft e r t h i n -l a y e r c h r o m a t o g r a p h y . A n a l y s i s o f s u r f a c t a n t p r ep a r a t i o n s f r o m s p u t u m o f c y s t i c f i b r o s i s p a t i e n t s s h o w a s i g n i f i c a n t d e c r e a s e i n p h o s p h a t i d y l c h o l i n e a n d p h o s p h a t id y l g l y c e r o l , a n d a n i n c r e a s e i n s p h i n g o m y e l i n a Fifteen infants (3 wks t o 8 mth) treated for bronchiolitis were monitored while in , head-box oxygen (total of 840 hrs) with Sa02, pulse rate, activity, microphone, ECG heart rate, chest and abdominal excursion, were recorded to a computer aided display and analysis system (CARDAS). 8 were term and 7 were ex-preterm infants.
n d p h o s p h at i d y l e t h a n o l a m i n e . T h e W t o FL r a t i o o f p h o s p h a t i d y l c h o li n e w a s i n c r e a s e d i n c y s t i c f i b r o s i s , i n d i c a t i n g a d e c r e as e d s a t u r a t i o n o f b r o n c h i a l p h o s p h a t i d y l c h o l i n e i n t h e s e p a t i e n t s .
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Sleep disuption was marLed. Term infants had tachypnea, range in quiet sleep ( 1) The responses of ex-prrterm infants are consistent with inhibitory mechanisms prevailing over excitatory ones from Obstruction o r airway irritation since they had minimal chest wall distortion and more apnea, apparently promoted by hyperoxia in some of them.
21 Clinical staff were unaware of these events and were misled by intermittent s a d 2 measurements, not recognising hyperoxia, apnea, or true from false hypoxemia. Hieh denendencv care was orobablv unnecessarily prolonged by relying on In virro T, (aerosol) was less than 10 sec in a polycarbonate holding chamber compared to a T, (aerosol) of longer than 3 0 sec in a steel holding cdamber. A prototype holding chamber of 220 m L was cast in steel, and was equipped with a twoway low-resistance valve with a small dead space to ensure a rectified inspiratory flow from the spacer and expiratory flow outside the spacer. This prototype was tested against a traditional 750 mL polycarbonate single-valved holding chamber for the delivery of budesonide aerosol from P-MDI to children in the age-range of 0-7 years suspected of asrhma. The polycarbonate was primed with benzalkonium chloride prior to use to avoid the confounding effect of the material. Both holding chambers were equipped with closely fitted face masks for children less than 48 months old. One hundred and sixty five children suspected of asthma, equally distributed as regards age from 0 to 7 years, inhaled one dose of budesonide from one of the holding chambers for 60 seconds. A filter was interposed between the holding chamber and the face mask adsorbing all particles delivered to the child.
The mean dose fraction inhaled from the prototype approximated 38% irrespective of age, whereas the large-volume holding chamber exhibited a highly significant agerelated decrease from approximately 44% in the older children down to 19% in infants. The difference in the doses of aerosol delivered was significant among children less than 3 years of age. In conclusion, a small-volume holding chamber of steel with valve control of both in-and exhalation and a face mask would improve for the treatment of young children and infants with aerosol from P-MDI.
